Effective April 1, Jennifer (Piper) Below, PhD, will lead VGI, the intellectual hub for genomics research at Vanderbilt University Medical Center and Vanderbilt University.

A new study will use innovative methods developed at VUMC to look for drugs already approved for other uses that could potentially be repurposed to treat Alzheimer’s.

The National Scleroderma Foundation has recognized Vanderbilt University Medical Center as a Designated Scleroderma Research and Treatment Center for the second time since 2022.

In a new study recently published in JAMA Network Open by VUMC researchers, including Kelsie Full, PhD, MPH (Epidemiology), it was found that long-term trajectories of irregular sleep durations outside the optimal range increased the risk of death from all causes by as much as 29%.

Dr. Peek, professor of Medicine and director of the Division of Gastroenterology, Hepatology and Nutrition, has been elected vice president of the American Gastroenterological Association (AGA), the specialty’s primary and most influential international organization.

For the first time, a Vanderbilt Health patient has been implanted with a novel left atrial pressure monitoring device (the V-LAP device), part of a clinical trial being conducted at only five centers in the United States.

Adetola Kassim, MBBS (Hematology and Oncology), is co-first author of the paper that reported of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.

The MNPS Certificated Employee Health Plan covers 6,500 active teachers plus 11,500 retirees and dependents.

Andreana Holowatyj, PhD, MSCI (Epidemiology), is chair of the Scientific Advisory Board for the ACPMP Research Foundation, and the article’s lead author.